Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Other influenza virion proteins present as minor antigens refers to the set of influenza virus proteins that are not the primary surface glycoproteins, Hemagglutinin (HA) and Neuraminidase (NA) (NIH, 2023). This category encompasses internal structural proteins such as the Nucleoprotein (NP) and Matrix protein 1 (M1), the M2 ion channel, and the RNA-dependent RNA polymerase subunits PA, PB1, and PB2 (Nature Reviews Microbiology, 2018). While HA and NA are the main targets for neutralizing antibodies, these minor antigens are highly conserved across different influenza strains, making them significant targets for universal influenza vaccines designed to elicit cross-reactive T-cell responses (Journal of Virology, 2020). The M2 protein functions as a proton-selective ion channel essential for viral uncoating and was the target of adamantane antivirals, although widespread resistance has limited their current clinical utility (CDC, 2022). More recently, the polymerase complex has become a focus for new classes of inhibitors like Baloxavir marboxil, which targets the PA subunit to prevent viral replication (Microbiology and Molecular Biology Reviews, 2015).
Inhibition of the M2 ion channel, inhibition of the viral RNA polymerase complex, or induction of cross-reactive T-cell immunity
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other influenza virion proteins present as minor antigens.